academic article

• Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke..  Molecular brain.  6:-. 2013
• Neuroprotective role of a brain-enriched tyrosine phosphatase, STEP, in focal cerebral ischemia. 2013
• Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment..  Stroke; a journal of cerebral circulation.  42:1345-1350. 2011
• Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice..  J. Neuroinflammation.  8:-. 2011
• Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity..  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.  30:370-380. 2010
• Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia. 2010
• Diverse Roles of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Neurological Diseases.  Neuroscience.  158:983-994. 2009
• Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats..  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.  29:308-316. 2009
• Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke. 2009
• Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat..  The Journal of pharmacology and experimental therapeutics.  323:488-498. 2007